Literature DB >> 25692254

Development of a Nonhuman Primate (Rhesus Macaque) Model of Uncontrolled Traumatic Liver Hemorrhage.

Forest R Sheppard1, Antoni Macko, Darren M Fryer, Kassandra M Ozuna, Alexander K Brown, Randy F Crossland, Douglas K Tadaki.   

Abstract

Hemorrhage is the leading cause of potentially survivable trauma mortality, necessitating the development of improved therapeutic interventions. The objective of this study was to develop and characterize a reproducible clinically translatable nonhuman primate model of uncontrolled severe hemorrhage. Such a model is required to facilitate the development and meaningful evaluation of human-derived therapeutics. In Rhesus macaques, a laparoscopic left-lobe hepatectomy of 25% (n = 2), 50% (n = 4), or 60% (n = 6) was performed at T = 0 min, with no attempt at hemorrhage control until T = 120 min. A constant-rate infusion of normal saline was administered between T = 15 and 120 min to a total volume of 20 mL/kg. At T = 120 min, a laparotomy was performed to gain surgical hemostasis and quantify blood loss. Physiological parameters were recorded, and blood samples were collected at defined intervals until termination of the study at T = 480 min. Statistical analyses used Student t tests, with P < 0.05 considered statistically significant. Results are reported as mean ± SEM. The calculated percent blood loss for the 25% hepatectomy group was negligible (2.3% ± 0.2%), whereas the 50% and 60% hepatectomy groups exhibited 26.6% ± 7.1% and 24.9% ± 3.8% blood loss, respectively. At T = 5 min, blood pressure for the 25%, 50%, and 60% hepatectomy groups was reduced by 13.8%, 60.8%, and 63.2% from the respective baseline values (P < 0.05). In the 60% hepatectomy group, alterations in thromboelastometry parameters and systemic inflammatory markers were observed. The development of a translatable nonhuman primate model of uncontrolled hemorrhage is an ongoing process. This study demonstrates that 60% hepatectomy offers a significant reproducible injury applicable for the evaluation of human-derived therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692254     DOI: 10.1097/SHK.0000000000000335

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Selective organ ischaemia/reperfusion identifies liver as the key driver of the post-injury plasma metabolome derangements.

Authors:  Nathan Clendenen; Geoffrey R Nunns; Ernest E Moore; Eduardo Gonzalez; Michael Chapman; Julie A Reisz; Erik Peltz; Miguel Fragoso; Travis Nemkov; Matthew J Wither; Angela Sauaia; Christopher C Silliman; Kirk Hansen; Anirban Banerjee; Angelo D'Alessandro; Hunter B Moore
Journal:  Blood Transfus       Date:  2018-12-13       Impact factor: 3.443

2.  Red blood cells in hemorrhagic shock: a critical role for glutaminolysis in fueling alanine transamination in rats.

Authors:  Julie A Reisz; Anne L Slaughter; Rachel Culp-Hill; Ernest E Moore; Christopher C Silliman; Miguel Fragoso; Erik D Peltz; Kirk C Hansen; Anirban Banerjee; Angelo D'Alessandro
Journal:  Blood Adv       Date:  2017-07-14

3.  Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring.

Authors:  Mitchell Dyer; Shannon Haldeman; Andres Gutierrez; Lauryn Kohut; Anirban Sen Gupta; Matthew D Neal
Journal:  J Vis Exp       Date:  2017-05-21       Impact factor: 1.355

4.  Biodegradable shape memory polymer foams with appropriate thermal properties for hemostatic applications.

Authors:  Lindy K Jang; Grace K Fletcher; Mary Beth B Monroe; Duncan J Maitland
Journal:  J Biomed Mater Res A       Date:  2020-02-21       Impact factor: 4.396

5.  Host responses to concurrent combined injuries in non-human primates.

Authors:  Matthew J Bradley; Diego A Vicente; Benjamin A Bograd; Erin M Sanders; Crystal L Leonhardt; Eric A Elster; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2017-11-02       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.